Welcome to LookChem.com Sign In|Join Free

CAS

  • or

518015-09-3

5-Methyl-1,3,4-thiadiazole-2-carbonitrile is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

518015-09-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 518015-09-3 Structure

  • Basic information

    1. Product Name: 5-Methyl-1,3,4-thiadiazole-2-carbonitrile
    2. Synonyms: 5-Methyl-1,3,4-thiadiazole-2-carbonitrile
    3. CAS NO:518015-09-3
    4. Molecular Formula: C4H3N3S
    5. Molecular Weight: 125.15172
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 518015-09-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 5-Methyl-1,3,4-thiadiazole-2-carbonitrile(CAS DataBase Reference)
    10. NIST Chemistry Reference: 5-Methyl-1,3,4-thiadiazole-2-carbonitrile(518015-09-3)
    11. EPA Substance Registry System: 5-Methyl-1,3,4-thiadiazole-2-carbonitrile(518015-09-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 518015-09-3(Hazardous Substances Data)

518015-09-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 518015-09-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,1,8,0,1 and 5 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 518015-09:
(8*5)+(7*1)+(6*8)+(5*0)+(4*1)+(3*5)+(2*0)+(1*9)=123
123 % 10 = 3
So 518015-09-3 is a valid CAS Registry Number.

518015-09-3Upstream product

518015-09-3Downstream Products

518015-09-3Relevant articles and documents

Heteroaryl substituted dihydro pyrimidine compounds and their use in medicine

-

Paragraph 0337; 0340; 0341; 0625; 0628; 0629, (2018/02/23)

The invention relates to heteroaryl-substituted dihydropyrimidine compounds and application thereof in medicines, particularly application in medicines for treating and preventing hepatitis B. Particularly, the invention relates to compounds disclosed as general formula (I) or (Ia), or enantiomers, diastereoisomers, hydrates, solvates or pharmaceutically acceptable salts thereof, wherein the variables are defined in the specification. The invention also relates to application of the compounds disclosed as general formula (I) or (Ia), or enantiomers, diastereoisomers, hydrates, solvates or pharmaceutically acceptable salts thereof, especially application in medicines for treating and preventing hepatitis B.

DIHYDROPYRIMIDINE COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS

-

Paragraph 0716 - 0717; 0791 - 0794, (2015/06/10)

Provided herein are dihydropyrimidine compounds and their pharmaceutical applications, especially for use in treating and preventing HBV diseases. Specifically, provided herein are compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof, wherein the variables of the formulas are as defined in the specification. Also provided herein is the use of the compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof for treating and preventing HBV diseases.

DIHYDROPYRIMIDINE COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS

-

Paragraph 00296; 00324, (2014/03/25)

Provided herein are dihydropyrimidine compounds and their pharmaceutical　applications, especially for use in treating and preventing HBV diseases. Specifically,provided herein are compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof, wherein the variables of the formulas are as defined in the specification. Also provided herein is the use of the compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof for treating and preventing HBV diseases.

Heteroaryl substituted amidinyl and imidazolyl compounds and methods employing same for the treatment of inflammation

-

, (2008/06/13)

In accordance with the present invention, there are provided compounds and pharmaceutical compositions useful for the selective inhibition of COX-2 in the presence of COX-1. As a result, invention compounds and compositions provide anti-inflammatory relie

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 518015-09-3